BRAF Mutants Evade ERK-Dependent Feedback by Different Mechanisms that Determine Their Sensitivity to Pharmacologic Inhibition von Yao, Zhan, Torres, Neilawattie M., Tao, Anthony, Gao, Yijun, Luo, Lusong, Li, Qi, de Stanchina, Elisa, Abdel-Wahab, Omar, Solit, David B., Poulikakos, Poulikos I., Rosen, Neal

Volltext

Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS von Yao, Zhan, Yaeger, Rona, Rodrik-Outmezguine, Vanessa S., Tao, Anthony, Torres, Neilawattie M., Chang, Matthew T., Drosten, Matthias, Zhao, Huiyong, Cecchi, Fabiola, Hembrough, Todd, Michels, Judith, Baumert, Hervé, Miles, Linde, Campbell, Naomi M., de Stanchina, Elisa, Solit, David B., Barbacid, Mariano, Taylor, Barry S., Rosen, Neal

Volltext

Allele-Specific Mechanisms of Activation of MEK1 Mutants Determine Their Properties von Gao, Yijun, Chang, Matthew T, McKay, Daniel, Na, Na, Zhou, Bing, Yaeger, Rona, Torres, Neilawattie M, Muniz, Keven, Drosten, Matthias, Barbacid, Mariano, Caponigro, Giordano, Stuart, Darrin, Moebitz, Henrik, Solit, David B, Abdel-Wahab, Omar, Taylor, Barry S, Yao, Zhan, Rosen, Neal

Volltext

Abstract 4078: Tumors with class 3 BRAF mutants are sensitive to the inhibition of activated RAS von Yao, Zhan, Yaeger, Rona, Rodrik-Outmezguine, Vanessa S., Tao, Anthony, Torres, Neilawattie M., Chang, Matthew T., Drosten, Matthias, Zhao, Huiyong, Cecchi, Fabiola, Hembrough, Todd, Michels, Judith, Baumert, Hervé, Miles, Linde, Campbell, Naomi M., Stanchina, Elisa de, Solit, David B., Barbacid, Mariano, Taylor, Barry S., Rosen, Neal

Volltext